Loading…
CIK 0001839435 • 7 13F filings • May 15, 2025 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("octagon-capital-advisors-lp","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| ABIVAX SA | SPONSORED ADS | $102.0M | 12.4%Prev: 17.1% | 756,000 SH | Decreased-569,000 SH |
| ALUMIS INC | COM | $24.7M | 3.0% | 2,530,700 SH | New |
| ARRIVENT BIOPHARMA INC | COM | $39.7M | 4.8%Prev: 5.5% | 1,971,054 SH | Increased |
| BIOAGE LABS INC | COM | $21.1M | 2.6% | 1,598,000 SH | New |
| BRIDGEBIO ONCOLOGY THERAPEUT | COM NEW | $13.1M | 1.6%Prev: 1.8% | 1,043,110 SH | Increased |
| CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | $18.8M | 2.3%Prev: 3.1% | 750,000 SH | Decreased-80,000 SH |
| CG ONCOLOGY INC | COM | $24.9M | 3.0% | 600,000 SH | New |
| CIDARA THERAPEUTICS INC | COM NEW | $22.1M | 2.7%Prev: 4.4% | 100,000 SH | Decreased-200,000 SH |
| COGENT BIOSCIENCES INC | COM | $83.5M | 10.1%Prev: 6.3% | 2,350,000 SH | Increased-524,111 SH |
| CORBUS PHARMACEUTICALS HLDGS | COM NEW | $7.8M | 0.9%Prev: 2.1% | 955,000 SH | Decreased-160,000 SH |
| DBV TECHNOLOGIES S A | SPONSORED ADS | $11.0M | 1.3%Prev: 1.5% | 574,200 SH | Increased-443,821 SH |
| DIANTHUS THERAPEUTICS INC | COM | $99.6M | 12.1%Prev: 14.4% | 2,416,667 SH | Increased |
| EVOMMUNE INC | COM SHS | $8.6M | 1.0% | 500,000 SH | New |
| GOSSAMER BIO INC | COM | $43.1M | 5.2%Prev: 6.8% | 13,915,371 SH | Decreased-3,134,629 SH |
| KALVISTA PHARMACEUTICALS INC | COM | $20.6M | 2.5%Prev: 2.4% | 1,273,333 SH | Increased |
| KYMERA THERAPEUTICS INC | COM | $41.6M | 5.1%Prev: 3.1% | 535,000 SH | Increased+175,000 SH |
| LEXEO THERAPEUTICS INC | COM | $17.1M | 2.1% | 1,725,000 SH | New |
| MIND MEDICINE MINDMED INC | COM NEW | $29.9M | 3.6%Prev: 3.8% | 2,230,000 SH | Increased+100,000 SH |
| OCULAR THERAPEUTIX INC | COM | $31.9M | 3.9%Prev: 4.6% | 2,623,600 SH | Increased-400 SH |
| PALISADE BIO INC | COM | $22.5M | 2.7% | 9,567,898 SH | New |
| PEPGEN INC | COM | $4.6M | 0.6%Prev: 0.5% | 700,000 SH | Increased |
| PHARVARIS N V | COM | $18.6M | 2.3%Prev: 2.7% | 671,465 SH | Increased-51,130 SH |
| PRECISION BIOSCIENCES INC | COM NEW | $8.0M | 1.0% | 1,917,995 SH | New |
| RAPT THERAPEUTICS INC | COM NEW | $19.4M | 2.4% | 574,000 SH | New |
| TAYSHA GENE THERAPIES INC | COM SHS | $48.7M | 5.9%Prev: 4.5% | 8,859,911 SH | Increased-207,589 SH |
| TREVI THERAPEUTICS INC | COM | $35.2M | 4.3%Prev: 3.9% | 2,815,000 SH | Increased |
| UNICYCIVE THERAPEUTICS INC | COM NEW | $5.8M | 0.7%Prev: 0.7% | 1,000,000 SH | Increased |
| 13F-HR |
| 0001839435-26-000004 |
| $1.11B |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0001839435-25-000007 | $455.6M | View |
| May 15, 2026 | Q1 2026 | 13F-HR | 0001839435-26-000003 | $903.6M | View |
| May 16, 2025 | Q1 2025 | 13F-HR/A | 0001839435-25-000005 | $516.8M | View |